VT News
Hannah Green

Hannah Green

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Crocs shares plunge due to declining Q3 sales, tariff impact, and shifting consumer behavior, leading the company to adjust its strategy to protect brand health and profitability.
  • Trump orders new census to exclude illegal immigrants, sparking legal challenges and political controversy.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Crocs shares plunge due to declining Q3 sales, tariff impact, and shifting consumer behavior, leading the company to adjust its strategy to protect brand health and profitability.
  • Trump orders new census to exclude illegal immigrants, sparking legal challenges and political controversy.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Hannah Green

Top Topics

Trending in U.S.

World

Sport